Altimmune, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Altimmune, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Altimmune, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 71.1M shares, a 32.4% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 71.1M +17.4M +32.4% Nov 8, 2024 10-Q 2024-11-12
Q2 2024 71.1M +18.4M +34.9% Aug 2, 2024 10-Q 2024-08-08
Q1 2024 70.9M +21.6M +43.8% Mar 22, 2024 10-K 2024-03-27
Q3 2023 53.7M +4.57M +9.3% Nov 3, 2023 10-Q 2023-11-07
Q2 2023 52.7M +4.15M +8.55% Aug 4, 2023 10-Q 2023-08-10
Q1 2023 49.3M +6.07M +14% May 5, 2023 10-Q 2023-05-11
Q3 2022 49.2M +9.42M +23.7% Nov 4, 2022 10-Q 2022-11-10
Q2 2022 48.5M +8.83M +22.2% Aug 5, 2022 10-Q 2022-08-11
Q1 2022 43.2M +6.07M +16.3% Mar 11, 2022 10-K 2022-03-15
Q3 2021 39.7M +6.67M +20.2% Nov 5, 2021 10-Q 2021-11-09
Q2 2021 39.7M +6.8M +20.7% Aug 6, 2021 10-Q 2021-08-10
Q1 2021 37.2M +21.8M +142% Feb 23, 2021 10-K 2021-02-25
Q3 2020 33.1M +17.7M +116% Nov 6, 2020 10-Q 2020-11-09
Q2 2020 32.9M +17.6M +115% Aug 7, 2020 10-Q 2020-08-11
Q1 2020 15.4M +1.91M +14.2% Mar 26, 2020 10-K 2020-03-27
Q3 2019 15.3M +6.58M +75.2% Nov 12, 2019 10-Q 2019-11-13
Q2 2019 15.3M -23.1M -60.1% Aug 13, 2019 10-Q 2019-08-13
Q1 2019 13.5M -8.82M -39.6% Mar 27, 2019 10-K 2019-04-01
Q3 2018 8.76M -6.9M -44.1% Nov 13, 2018 10-Q 2018-11-13
Q2 2018 38.5M +23.1M +150% Aug 14, 2018 10-Q 2018-08-14
Q1 2018 22.3M -46.5M -67.6% Mar 30, 2018 10-K 2018-04-02
Q3 2017 15.7M -51.1M -76.5% Nov 9, 2017 10-Q 2017-11-09
Q2 2017 15.4M -50.2M -76.5% Aug 8, 2017 10-Q 2017-08-14
Q1 2017 68.8M +3.56M +5.46% Mar 6, 2017 10-K 2017-03-14
Q3 2016 66.7M +2.28M +3.53% Nov 1, 2016 10-Q 2016-11-04
Q2 2016 65.6M +1.37M +2.13% Aug 1, 2016 10-Q 2016-08-04
Q1 2016 65.3M +1.62M +2.54% Mar 7, 2016 10-K 2016-03-11
Q3 2015 64.5M +1.08M +1.7% Nov 4, 2015 10-Q 2015-11-06
Q2 2015 64.2M +7.78M +13.8% Aug 3, 2015 10-Q 2015-08-05
Q1 2015 63.6M +10.1M +18.9% Mar 3, 2015 10-K 2015-03-11
Q3 2014 63.4M +11.1M +21.1% Nov 3, 2014 10-Q 2014-11-06
Q2 2014 56.4M +4.13M +7.9% Aug 1, 2014 10-Q 2014-08-05
Q1 2014 53.5M +5.16M +10.7% Mar 7, 2014 10-K 2014-03-11
Q3 2013 52.3M +3.94M +8.16% Nov 1, 2013 10-Q 2013-11-07
Q2 2013 52.3M +3.94M +8.16% Aug 2, 2013 10-Q 2013-08-08
Q1 2013 48.4M +31.5K +0.07% Feb 28, 2013 10-K 2013-03-14
Q3 2012 48.4M +83.9K +0.17% Nov 1, 2012 10-Q 2012-11-06
Q2 2012 48.4M +134K +0.28% Aug 1, 2012 10-Q 2012-08-07
Q1 2012 48.3M May 1, 2012 10-Q 2012-05-10
Q3 2011 48.3M Oct 31, 2011 10-Q 2011-11-09
Q2 2011 48.2M Aug 4, 2011 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.